Cannabis-derived epilepsy drug on the horizonA pharmaceutical formulation of purified cannabidiol, a cannabinoid without euphoric side effects, is expected to launch in the second half of this year.
New data released on clobazam for LGSRecent data were released on a long-term, open-label extension study evaluating clobazam for the adjunctive treatment of drop seizures.
Onfi (Clobazam tablets)New molecular entity: A benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients age 2 years or older.